RecruitingPhase 2Phase 3NCT06474247
Postbiotic as Adjunct Treatment for Vaginal Candidiasis
Use of Postbiotic as Adjunct Treatment for Vaginal Candidiasis in Women
Sponsor
Min-Tze LIONG
Enrollment
118 participants
Start Date
Jun 2, 2024
Study Type
INTERVENTIONAL
Conditions
Summary
This project aims to study the efficacy of intravaginal administration of postbiotic at 1g/day as an adjunct treatment against vaginal candidiasis in women for 4-weeks compared to placebo.
Eligibility
Sex: FEMALEMin Age: 18 YearsMax Age: 81 Years
Inclusion Criteria3
- Women who are sexually active
- Confirmed with candidiasis as confirmed via clinical observations which include creamy whitish vaginal discharge and vulva-vaginal itchiness
- Willing to commit throughout the experiment
Exclusion Criteria11
- Long term medication (6 months or more) for any illnesses
- Pregnant
- Menopaused
- Uterus and/or cervix removed
- Cervical intraepithelial neoplasia
- Vaginal suppository treatments within 4-weeks prior to entering the study
- Oral medication for vaginal illnesses or any vaginal therapy such as hormones and estrogen within 4-weeks prior to entering the study
- Have used vaginal estrogen cream, ring or tablet within 4-weeks prior to entering the study
- Have used vaginal moisturizers, lubricants or homeopathic preparations within 4-weeks prior to entering the study
- Have used spermicide agent within 4-weeks prior to entering the study
- Have pelvic or any gynecologic surgery 6-months prior to entering the study
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICEPostbiotic
Postbiotic at 1g/day as an adjunct treatment against vaginal candidiasis in women for 4-weeks
DEVICEPlacebo
Placebo at 1g/day as an adjunct treatment against vaginal candidiasis in women for 4-weeks
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06474247